Tanaka E, Misawa S, Kuroiwa Y
J Pharmacobiodyn. 1985 Sep;8(9):767-72. doi: 10.1248/bpb1978.8.767.
The effects of cimetidine and diethylaminoethyl 2,2-diphenylvalerate (SKF 525-A) on trimethadione (TMO) metabolism were examined in the rat. The pretreatment of rats with cimetidine (100 mg/kg, i.p.) or SKF 525-A (40 mg/kg, i.p.) resulted in a prolongation of half-life (T1/2), an increase in the area under the curve (AUC) and a decrease in the total body clearance (CL) of TMO. However, the apparent volume of distribution (Vd) of TMO was not changed. The activities of hepatic cytochrome P-450-dependent drug-oxidizing enzymes such as aminopyrine and TMO N-demethylase, and aniline hydroxylase activities were decreased by pretreatment of rats with cimetidine or SKF 525-A. Cytochrome P-450 contents were not changed. The inhibition of aminopyrine and TMO N-demethylase activities in the rat pretreated with cimetidine or SKF 525-A was noncompetitive. These results suggest that cimetidine and SKF 525-A inhibited TMO metabolism in a similar manner to the rat pretreated with their doses.
在大鼠中研究了西咪替丁和2,2 - 二苯基戊酸二乙氨基乙酯(SKF 525 - A)对三甲双酮(TMO)代谢的影响。用西咪替丁(100mg/kg,腹腔注射)或SKF 525 - A(40mg/kg,腹腔注射)预处理大鼠,导致TMO的半衰期(T1/2)延长、曲线下面积(AUC)增加以及全身清除率(CL)降低。然而,TMO的表观分布容积(Vd)未发生变化。用西咪替丁或SKF 525 - A预处理大鼠后,肝微粒体细胞色素P - 450依赖性药物氧化酶如氨基比林和TMO N - 脱甲基酶的活性以及苯胺羟化酶活性均降低。细胞色素P - 450含量未改变。用西咪替丁或SKF 525 - A预处理的大鼠中,氨基比林和TMO N - 脱甲基酶活性的抑制是非竞争性的。这些结果表明,西咪替丁和SKF 525 - A以与用它们的剂量预处理的大鼠相似的方式抑制TMO代谢。